...
首页> 外文期刊>Journal of interventional cardiology >The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.
【24h】

The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions.

机译:密歇根州心血管协会(BMC2)的Blue Cross Blue Shield在经皮冠状动脉介入治疗中的协作质量改进计划。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The past decade has been characterized by increased scrutiny of outcomes of surgical and percutaneous coronary interventions (PCIs). This increased scrutiny has led to the development of regional, state, and national databases for outcome assessment and for public reporting. This report describes the initial development of a regional, collaborative, cardiovascular consortium and the progress made so far by this collaborative group. In 1997, a group of hospitals in the state Michigan agreed to create a regional collaborative consortium for the development of a quality improvement program in interventional cardiology. The project included the creation of a comprehensive database of PCIs to be used for risk assessment, feedback on absolute and risk-adjusted outcomes, and sharing of information. To date, information from nearly 20,000 PCIs have been collected. A risk prediction tool for death in the hospital and additional risk prediction tools for other outcomes have been developed from the data collected, and are currently used by the participating centers for risk assessment and for quality improvement. As the project enters into year 5, the participating centers are deeply engaged in the quality improvement phase, and expansion to a total of 17 hospitals with active PCI programs is in process. In conclusion, the Blue Cross Blue Shield of Michigan Cardiovascular Consortium is an example of a regional collaborative effort to assess and improve quality of care and outcomes that overcome the barriers of traditional market and academic competition.
机译:过去十年的特点是对外科和经皮冠状动脉介入治疗(PCI)的结果进行了越来越严格的审查。日益严格的审查导致开发了用于结果评估和公共报告的区域,州和国家数据库。本报告介绍了一个区域性,协作性心血管联盟的初步发展情况,以及该协作小组迄今所取得的进展。 1997年,密歇根州的一家医院集团同意建立一个区域合作联盟,以开发介入心脏病学的质量改善计划。该项目包括创建一个完整的PCI数据库,用于风险评估,对绝对和风险调整后结果的反馈以及信息共享。迄今为止,已经收集了将近20,000个PCI的信息。根据收集到的数据,已经开发出了一种用于医院死亡的风险预测工具和用于其他结果的其他风险预测工具,参与中心目前正在使用这些工具进行风险评估和质量改善。随着该项目进入第5年,参与中心将深入开展质量改进阶段,目前正在向拥有有效PCI计划的17家医院扩展。总之,密歇根州心血管联盟的“蓝十字蓝盾”是区域合作努力的一个示例,该评估旨在评估和改善医疗质量和成果,从而克服传统市场和学术竞争的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号